December 29, 2025

When Dinner Becomes Deadly Hours Later

Postmortem testing showed extreme tryptase elevation and clinically relevant alpha-gal–specific immunoglobulin E despite low absolute levels.

Conexiant

December 19, 2025

AHL Quorum Sensing in Dental Plaque?

Investigators find N-acyl homoserine lactone quorum sensing influences dental plaque biofilms and oral microbiome shifts under different oxygen conditions.

Conexiant

December 12, 2025

Autism's 3-Hit Model Targets Mitochondria

Three necessary metabolic disruptions converge on cell danger response, suggesting prevention opportunities.

Conexiant

December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

Is WHO Mpox Monitoring Window Too Short?

New data challenge WHO's 21-day observation window, as nearly one-quarter of infections develop rash after recommended surveillance period ends.

Conexiant

December 08, 2025

The Case of the Hospital That Isn’t

A bureaucratic showdown over North Carolina’s certificate-of-need laws has stalled a critical hospital project, straining care in the state’s mountain communities.

Conexiant

December 05, 2025

On the Edge of a Measles Comeback?

New analysis examines rising U.S. measles outbreaks, associated clinical risks, and the potential loss of measles-elimination status.

KFF Health News

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

A recent study in the Journal of Investigative Dermatology identified potential early factors in the development of hidradenitis suppurativa, involving apocrine gland damage and keratin release, offering insights into potential biomarkers for disease severity and progression.

Conexiant

June 24, 2024

Maternal Tdap Vaccine May Lower Infant Pertussis

Study shows maternal Tdap vaccination significantly reduces pertussis incidence in infants younger than 2 months, supporting its use during pregnancy.

Conexiant